drugset / Trial / NCT02929862
Study of LYC-55716 in Adult Subjects With Locally Advanced or Metastatic Cancer
NaSingle-groupOpen-labelTreatment
Summary
This is a Phase 1/2A study designed to evaluate the safety and tolerability of increased repeated doses of LYC-55716 in subjects with locally advanced or metastatic solid tumors.
Timeline
- Start
- 2016-12
- Primary completion
- 2019-05-31
- Completion
- 2019-05-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CINTIRORGON | Small molecule | — | Oral |